Contract award · HDTRA121C0005
ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSVAG CHIMERIC VIRUS PLATFORM
Awarded to INTERNATIONAL AIDS VACCINE INITATIVE INC. · CAGE 44YM6
Latest reported total obligated
Not reported
Net observed obligations
$26.3M
Observed contract actions
13
Observed period
FY2021–FY2024
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorINTERNATIONAL AIDS VACCINE INITATIVE INC.
CAGE44YM6
CustomerDefense Threat Reduction Agency
Performance locationNEW YORK, NEW YORK, UNITED STATES
Procurement details
First observed actionOct 5, 2020
Latest observed actionSep 16, 2024
PSCAC33
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION
PricingCOST PLUS FIXED FEE
Annual observed obligations
FY2021
$14.7M
FY2022
$5.3M
FY2023
$5.3M
FY2024
$960.5K
Continue exploring
Ask Mimir about HDTRA121C0005
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.